Loading...
XKRX
005500
Market cap174mUSD
Dec 05, Last price  
20,950.00KRW
1D
0.96%
1Q
10.26%
Jan 2017
-39.71%
Name

Samjin Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XKRX:005500 chart
P/E
6.55
P/S
0.83
EPS
3,200.66
Div Yield, %
—
Shrs. gr., 5y
0.50%
Rev. gr., 5y
4.97%
Revenues
308.35b
+5.55%
137,112,663,000147,996,742,000165,388,711,000200,410,515,000201,756,103,660185,702,080,230192,006,713,100201,305,289,860216,511,471,520239,312,893,940245,271,927,860260,016,571,280241,926,177,090235,164,889,490250,070,355,500274,031,808,450292,128,533,737308,349,934,000
Net income
39.23b
+107.52%
6,434,603,0006,731,815,0007,044,974,00010,477,195,0007,062,463,89010,638,443,4907,878,193,57020,716,717,57027,043,171,46030,174,331,51035,795,824,75025,526,185,48011,880,757,00027,879,308,25028,404,156,00021,893,835,62018,905,784,04039,232,983,000
CFO
38.15b
+357.82%
-5,744,629,000-1,503,696,0002,135,391,00016,835,715,00012,670,311,56033,931,501,2207,374,337,48032,406,391,92018,935,641,49048,657,842,14037,283,674,16030,081,823,68023,633,082,80023,860,500,18023,967,389,57017,293,228,4508,333,560,99038,152,788,000
Dividend
Dec 27, 2023800 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer's disease, Parkinson's disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.
URL
https://www.samjinpharm.co.kr/
IPO date
Jun 18, 1988
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT